Changes in Neurodevelopmental Outcomes From Age 2 to 10 Years for Children Born Extremely Preterm

Genevieve L Taylor1, Robert M Joseph2, Karl C K Kuban3

  • 1Department of Pediatrics, and gtaylor@med.unc.edu.

Pediatrics
|April 7, 2021
PubMed

Insights

Neurodevelopmental impairment (NDI) in extremely preterm infants at 2 years old only weakly predicts outcomes at 10 years. Many children initially diagnosed with moderate to profound NDI show no or mild impairment later.

Area of Science:

  • Neonatology
  • Developmental Pediatrics
  • Pediatric Neurology

Background:

  • Neurodevelopmental impairment (NDI) is a critical outcome for extremely preterm infants (<28 weeks' gestation).
  • Current evidence-based care relies on NDI research, but the predictive value of early NDI for long-term outcomes is not well understood.

Purpose of the Study:

  • To evaluate the relationship between neurodevelopmental status at 2 years and 10 years in extremely preterm infants.
  • To compare a standard 2-year NDI definition with a novel 10-year NDI definition incorporating epilepsy and autism spectrum disorder (ASD).

Main Methods:

  • Utilized data from the Extremely Low Gestational Age Newborn Study cohort.
  • Classified 2-year NDI using established Neonatal Research Network criteria.
  • Developed and applied a 10-year NDI definition including epilepsy and ASD at age 10.

Main Results:

  • Of 1506 infants, 80% survived; 802 had data for both 2- and 10-year NDI classification.
  • Only 36% of those with profound NDI at 2 years had none to mild NDI at 10 years.
  • 63% of those with moderate to severe NDI at 2 years had none to mild NDI at 10 years, indicating weak predictive agreement (Cohen's κ = 0.34).

Conclusions:

  • Infant NDI, as defined in this study, has limited predictive power for neurodevelopmental outcomes in middle childhood.
  • Findings offer a hopeful outlook for parents, showing significant improvement in neurodevelopmental status for many extremely preterm survivors between 2 and 10 years.
Abstract

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
43.7K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
527
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.6K